CTLA4 and cancer: ICIs are antibodies against the immune checkpoint molecules Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) and Programed Death Ligand 1 (PD-L1), preventing cancer cells from deactivating T-cells [5,8,55].